RMR Wealth Builders’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,398
Closed -$343K 199
2022
Q3
$343K Buy
+1,398
New +$378K 0.08% 127
2022
Q2
Sell
-758
Closed -$251K 224
2022
Q1
$251K Buy
+758
New +$233K 0.05% 174
2021
Q4
Sell
-683
Closed -$222K 208
2021
Q3
$222K Hold
683
0.07% 171
2021
Q2
$213K Sell
683
-236
-26% -$72.4K 0.07% 167
2021
Q1
$293K Buy
919
+116
+14% +$37.1K 0.08% 137
2020
Q4
$260K Sell
803
-293
-27% -$81K 0.13% 126
2020
Q3
$304K Buy
1,096
+293
+36% +$84.4K 0.08% 153
2020
Q2
$194K Buy
+803
New +$161K 0.17% 117
2019
Q4
$117K Buy
+683
New +$127K 0.11% 160

Other funds holding ABMD

RMR Wealth Builders's ABMD Position: Q4 2022 in Review

RMR Wealth Builders sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,398 shares — an estimated $343K sold.

RMR Wealth Builders first reported a position in ABMD in Q4 2019 and held it in 9 quarters. The position peaked at $343K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • RMR Wealth Builders reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • RMR Wealth Builders sold 1,398 Abiomed Inc shares in Q4 2022, an estimated $343K.
  • RMR Wealth Builders first reported a position in Abiomed Inc in Q4 2019 and held it in 9 quarters.
  • RMR Wealth Builders's Abiomed Inc position peaked at $343K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on RMR Wealth Builders's 13F filing for Q4 2022, filed 2 Feb 2023.